Powder: -20°C for 3 years | In solvent: -80°C for 2 years
AZD-6370 is a Glucokinase activator. AZD-6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and food. AZD-6370 do not affect the central counterregulatory response to hypoglycemia in healthy males.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 970.00
$ 776.00
|
|
50 mg | 6-8 weeks | $ 1,980.00
$ 1,584.00
|
|
100 mg | 6-8 weeks | $ 2,500.00
$ 2,000.00
|
Description | AZD-6370 is a glucokinase activator. AZD-6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and food. AZD-6370 do not affect the central counterregulatory response to hypoglycemia in healthy males. |
Synonyms | AZD-6370, AZD 6370 |
Molecular Weight | 445.49 |
Formula | C21H23N3O6S |
CAS No. | 752239-85-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD6370 752239-85-3 AZD-6370 AZD 6370 inhibitor inhibit